Skip to content
Urban Network Zone

Zimbabwe Declines ‘One-Sided’ US Health Aid Deal Due to Information Concerns

Medical funding image
The proposed US funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has declined a significant American health deal valued at $367m (£272m) spanning five years over Washington's demand for confidential information.

This move was revealed following a official document dated December was disclosed, indicating that President Emmerson Mnangagwa felt the agreement was "skewed".

A government spokesperson has since clarified that the US was requesting health data for scientific study and profit but refused to share the resulting advantages from future treatments.

"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged more dialogue to find a agreement suitable to all parties so the nation's vital HIV programme can continue.

Broader Context

This development comes after a similar situation in Kenya, where a court suspended a related deal with the US after legal challenges were raised about the security of citizens' health data.

Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had managed assistance for the American government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government agreements to enhance transparency and responsibility.

As per statements, Sixteen African countries have so far agreed to these new agreements, representing over $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this collaboration might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy through US-supported initiatives," the Ambassador said.

However, official spokesman Nick Mangwana argued the arrangement was "unfair".

"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.

"Put simply, our country would supply the basic resources for scientific discovery with no assurance that the end products would be available to our people should a future pandemic emerge."

Sovereignty and Global Health

Mangwana further noted that the American exit from the global health body and its pursuit of one-on-one deals were upending frameworks already established via the global health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.

"This framework is designed to guarantee that when a nation contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We are open to continued discussions with our US partners on how subsequent collaboration might be arranged in a manner that respects the sovereignty and interests of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that talks must proceed since a large portion of the nation's HIV programmes relied on foreign aid.

"If specific concerns exist, including those involving information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it said.

The situation highlights the complex debate between receiving crucial international aid and protecting national sovereignty in an increasingly data-driven world.

About the author

James Baker

Lena is a freelance journalist covering urban culture, streetwear, and emerging music scenes across Europe.

Urban Network Zone

Type to search articles.